Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Library design and virtual screening using multiple 4-point pharmacophore fingerprints.

J S Mason1, D L Cheney

  • 1Department of Macromolecular Structure, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, NJ 08543, USA. jonathan.mason@bms.com

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing
|July 21, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Resource limitation and responses to rivals in males of the fruit fly Drosophila melanogaster.

Journal of evolutionary biology·2016
Same author

Just-in-Time Compound Pooling Increases Primary Screening Capacity without Compromising Screening Quality.

Journal of biomolecular screening·2015
Same author

Design of reflection retarders by use of nonnegative film-substrate systems.

Journal of the Optical Society of America. A, Optics, image science, and vision·2005
Same author

Cognitive strategies and the representation of social relations by monkeys.

Nebraska Symposium on Motivation. Nebraska Symposium on Motivation·2002
Same author

Development of infant baboons' responses to graded bark variants.

Proceedings. Biological sciences·2001
Same author

3-D pharmacophores in drug discovery.

Current pharmaceutical design·2001
Same journal

Trust, Reproducibility, and Progress: The Roles of Independent Blind Prediction and Assessment and Benchmarking in Computational Biology.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing·2026
Same journal

The Evolving Cyberinfrastructure at the National Institutes of Health to Support Data and AI in Biomedical Research.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing·2026
Same journal

Applications of AI & ML in Biomanufacturing of Cell and Gene Therapies.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing·2026
Same journal

AI for Health: Leveraging Artificial Intelligence to Revolutionize Healthcare.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing·2026
Same journal

Workshop Introduction: Advances of AI Methods in Single Cell Spatial Omics.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing·2026
Same journal

DRIVE-KG: Enhancing variant-phenotype association discovery in understudied complex diseases using heterogeneous knowledge graphs.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing·2026
See all related articles

This study introduces a novel method using multiple 4-point three-dimensional (3-D) pharmacophores for designing compound libraries and virtual screening. The approach enhances structure-based drug design by incorporating target site shape as a constraint for more accurate compound matching.

Area of Science:

  • Computational chemistry
  • Medicinal chemistry
  • Drug discovery

Background:

  • Three-dimensional (3-D) pharmacophores are crucial for understanding molecular interactions in drug discovery.
  • Current methods for designing combinatorial libraries and virtual screening can be computationally intensive.
  • Integrating structural information of protein targets can improve the accuracy of virtual screening and library design.

Purpose of the Study:

  • To present a method utilizing multiple 4-point 3-D pharmacophores for combinatorial library design and virtual screening.
  • To introduce an extension for structure-based design that incorporates the target protein site's shape as a constraint.
  • To enable quantitative assessment of how well compounds or libraries match pharmacophoric hypotheses within a target site.

Main Methods:

Related Experiment Videos

  • Calculation of 3-D pharmacophoric fingerprints for ligands and protein sites.
  • Development of a common reference frame for comparing pharmacophores.
  • Implementation of a structure-based design extension using target site shape as an additional constraint.
  • Rapid searching of pharmacophoric fingerprints to identify common and differing shapes.

Main Results:

  • Demonstration of rapid searching capabilities for identifying 4-point pharmacophoric shapes in compounds and protein sites.
  • Quantification of the docking process based on the number and type of pharmacophoric hypotheses matched.
  • Improved accuracy in virtual screening and library design through the incorporation of target site shape.

Conclusions:

  • The proposed method offers an efficient and accurate approach for 3-D pharmacophore-based virtual screening and library design.
  • Incorporating target site shape as a constraint significantly enhances structure-based drug design.
  • This methodology facilitates a more quantitative evaluation of compound-target interactions, aiding in the identification of potential drug candidates.